Trademark: 90864476
Status Date
Wednesday, January 31, 2024
Filing Date
Wednesday, August 4, 2021
Published for Opposition
Tuesday, June 14, 2022
44 Providing medical information; providing medical information relating to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders
42 Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of cognitive impairment associated with schizophrenia and mental illness and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of cognitive impairment associated with schizophrenia and mental illness and disorders, and evaluating epidemiological results for treatments for cognitive impairment associated with schizophrenia and mental illness and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for cognitive impairment associated with schizophrenia and mental illness and disorders
Feb 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2024
Sou Extension 3 Granted
Jan 31, 2024
Sou Extension 3 Filed
Jan 31, 2024
Sou Teas Extension Received
Jun 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2023
Sou Extension 2 Granted
Jun 28, 2023
Sou Extension 2 Filed
Jun 28, 2023
Sou Teas Extension Received
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2023
Sou Extension 1 Granted
Feb 6, 2023
Sou Extension 1 Filed
Feb 6, 2023
Sou Teas Extension Received
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 9, 2022
Assigned To Lie
May 5, 2022
Approved For Pub - Principal Register
May 5, 2022
Examiner's Amendment Entered
May 5, 2022
Notification Of Examiners Amendment E-Mailed
May 5, 2022
Examiners Amendment E-Mailed
May 5, 2022
Examiners Amendment -Written
May 3, 2022
Assigned To Examiner
Sep 29, 2021
New Application Office Supplied Data Entered
Aug 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
